DekaBank Deutsche Girozentrale
UTMD icon

DekaBank Deutsche Girozentrale’s Utah Medical Products UTMD Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,787
Closed -$411K – 1158
2019
Q4 		$411K Sell
3,787
-1,975
-34% -$200K ﹤0.01% 865
2019
Q3 		$555K Buy
5,762
+1,359
+31% +$126K ﹤0.01% 759
2019
Q2 		$401K Buy
+4,403
New +$371K ﹤0.01% 947
2019
Q1 		– Sell
-3,950
Closed -$307K – 1256
2018
Q4 		$307K Buy
+3,950
New +$348K ﹤0.01% 908

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

DekaBank Deutsche Girozentrale's UTMD Position: Q1 2020 in Review

DekaBank Deutsche Girozentrale sold out of Utah Medical Products (UTMD) in Q1 2020, closing a stake of 3,787 shares — an estimated $411K sold.

DekaBank Deutsche Girozentrale first reported a position in UTMD in Q4 2018 and held it in 4 quarters. The position peaked at $555K in Q3 2019. 90 funds tracked by Wall St. Rank hold UTMD as of Q1 2020.

  • DekaBank Deutsche Girozentrale reported no remaining Utah Medical Products position as of Q1 2020 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 3,787 Utah Medical Products shares in Q1 2020, an estimated $411K.
  • DekaBank Deutsche Girozentrale first reported a position in Utah Medical Products in Q4 2018 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Utah Medical Products position peaked at $555K in Q3 2019.
  • 90 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2020.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2020, filed 14 May 2020.